🟢 Medtronic is trading 4.4% up today amid a broad healthcare rally and hernia-mesh trial focus

Medtronic is trading at $83.98 (+4.36%) following a broad rally in the healthcare sector and renewed attention on its ongoing legal proceedings.

• The healthcare sector rose 2.12%, driven by strong UnitedHealth earnings which provided a lift to medical technology names across the board.
• A jury trial regarding the Covidien hernia-mesh litigation commenced on July 15, 2026, keeping a significant legal overhang in focus for investors.
• No specific company earnings or guidance updates were issued to account for the move more directly.